Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-21-068230

Chief Commercial Officer gave up 9,532 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rabinowitz Michael Chief Commercial Officer 2021-12-28 Shares withheld for taxes −9,532 $12.98 $123,725 90,468 D
Loading xslF345X03/ownership.xml…